STYNDOVI Trademark

Trademark Overview


On Friday, September 15, 2023, a trademark application was filed for STYNDOVI with the United States Patent and Trademark Office. The USPTO has given the STYNDOVI trademark a serial number of 98182178. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 6, 2024. This trademark is owned by Aprecia Pharmaceuticals, LLC. The STYNDOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the treatment of parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness, lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy
styndovi

General Information


Serial Number98182178
Word MarkSTYNDOVI
Filing DateFriday, September 15, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the treatment of parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness, lightheadedness or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAprecia Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBlue Ash, OH 45242

Party NameAprecia Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBlue Ash, OH 45242

Trademark Events


Event DateEvent Description
Tuesday, September 19, 2023NEW APPLICATION ENTERED
Thursday, May 9, 2024ASSIGNED TO EXAMINER
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT